How Translational Research Will Make a Difference for Women With Breast Cancer

31 Jan

“From Bench to Bedside to Market — Envisioning How Translational Research Will Make a Difference for Women With Breast Cancer” — UCSF’s 2009 Breast Oncology Program Scientific Retreat — was held this week. The focus was on experimental therapeutics, molecular markers, clinical trials and early detection. Among the topics discussed was “How siRNA will Change Cancer Therapy.” Here are a few take-aways:

  • Many mutant proteins are not druggable. Cancer can adapt to tolerate targeted therapies.
  • Current process of developing cancer drugs is not working.
  • UCSF is developing a new paradigm of drug development through its pioneering siRNA research.
  • Ultimately these siRNA discoveries will help eliminate the pharma industry R&D “valley of death.”

To learn more, visit  UCSF’s Helen Diller Family Comprehensive Cancer Center site.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: